Related Experiment Video

Updated: Jun 17, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

Hemolytic uremic syndrome: Events of the past decade

Peter N McLaine1

  • 1Department of Pediatrics, University of Ottawa; Children's Hospital of Eastern Ontario; Canadian Pediatric Kidney Disease Research Centre, Ottawa, Ontario.

Paediatrics & Child Health
|January 5, 2010
PubMed

Insights

The Canadian Pediatric Kidney Disease Research Centre (CPKDRC) was established in 1985. Collaborative research has focused on childhood Hemolytic Uremic Syndrome (HUS) and E. coli infections.

Area of Science:

  • Pediatric Nephrology
  • Infectious Diseases
  • Epidemiology

Background:

  • The Canadian Pediatric Kidney Disease Research Centre (CPKDRC) was founded in 1985.
  • Collaborative research across Canadian pediatric centers has been central to its activities.

Purpose of the Study:

  • To outline the establishment and research initiatives of the CPKDRC.
  • To detail key studies on childhood Hemolytic Uremic Syndrome (HUS) and E. coli infections.
  • To project future research directions for HUS prevention and management.

Main Methods:

  • National Retrospective Study of Childhood Hemolytic Uremic Syndrome (HUS).
  • National Prospective Study of Risk Factors for Developing Escherichia coli O157:H7 Infection.
  • Intervention Studies for the Prevention of HUS.

Main Results:

  • Established a national collaborative network for pediatric kidney disease research.
  • Identified risk factors and intervention strategies for childhood HUS.
  • Laid groundwork for future research into HUS etiology and long-term outcomes.

Conclusions:

  • The CPKDRC has facilitated significant advancements in understanding and managing childhood HUS.
  • Future research will focus on identifying at-risk children and improving long-term renal health post-HUS.
  • Continued collaboration is essential for addressing pediatric kidney diseases.

Keywords:
Escherichia coli O157:H7Hemolytic uremic syndromeIntervention studiesRisk factors

Related Concept Videos

Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...